Related Experiment Videos
Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene
1Department of Opthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston 02114.
Abstract:
The transcription of a eukaryotic gene is a consequence of intricate interactions between members of a set of transcription factors. We describe here evidence indicating that at least two distinct DNA-binding factors play an important part in the transcription of the human retinoblastoma gene (Rb). One of the factors reacts with a sequence overlapping with a potential Sp1 recognition sequence in the promoter region of the gene, the other with a nearby ATF recognition sequence. We have identified two naturally occurring point mutations in these recognition sequences that cause hereditary retinoblastoma. The nuclear factors do not bind to the mutant sequences. We infer that these nuclear factors are necessary for the expression of the Rb gene and the suppression of cancer.
Insights
Two DNA-binding factors are crucial for human retinoblastoma (Rb) gene transcription. Mutations in their recognition sites cause hereditary retinoblastoma, indicating these factors suppress cancer.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Gene transcription involves complex interactions of transcription factors.
- The human retinoblastoma (Rb) gene plays a critical role in tumor suppression.
- Understanding Rb gene regulation is vital for cancer research.
Purpose of the Study:
- To identify DNA-binding factors involved in human Rb gene transcription.
- To investigate the role of specific DNA recognition sequences in Rb gene expression.
- To determine the impact of mutations in these sequences on hereditary retinoblastoma.
Main Methods:
- Analysis of DNA-binding factors interacting with the Rb gene promoter.
- Identification and characterization of point mutations in the Rb gene promoter.
- Assessment of nuclear factor binding to wild-type and mutant Rb gene sequences.
Main Results:
- Two distinct DNA-binding factors, one interacting with an Sp1-like sequence and another with an ATF sequence, are identified in the Rb gene promoter.
- Two naturally occurring point mutations within these recognition sequences are found in hereditary retinoblastoma patients.
- These nuclear factors fail to bind to the mutant DNA sequences.
Conclusions:
- The identified DNA-binding factors are essential for the proper transcription of the human Rb gene.
- Disruption of these factors' binding due to mutations contributes to the development of hereditary retinoblastoma.
- These findings suggest a mechanism by which Rb gene expression is regulated and cancer is suppressed.